Home/Genelux/Dr. Aladar A. Szalay, Ph.D.
DA

Dr. Aladar A. Szalay, Ph.D.

Founder and Chief Scientific Officer

Genelux

Therapeutic Areas

Genelux Pipeline

DrugIndicationPhase
Olvi-Vec (olvimulogene nanivacirepvec)Platinum-Resistant/Refractory Ovarian CancerPhase 2/3
Olvi-VecSmall Cell Lung Cancer (SCLC)Phase 2
GLX-401Undisclosed Solid TumorsPreclinical